Cellular therapy refers to the use of live cells to replace or repair a damaged organ system. The first widespread use of this approach occurred more than 50 years ago when hematopoietic stem cells (HSCs) from the bone marrow of a healthy donor (allogeneic) were used to replace the hematopoietic system of a recipient after it was ablated during chemo/radio therapy of leukemia, the recipient’s hematopoietic system being “collateral damage” during the eradication of the unwanted leukemia cells.
Trial Vocal Fold Injection Helps Predict Positive Outcomes
Patients who were allowed to test drive a vocal fold injection-and who later decided on a permanent augmentation-found that the trial treatment translated in positive outcomes, researchers have found.
Innovative Doctors + Better Technology = Practice Changess
Part 1 of a series
Salivary Gland Malignancies: Diagnosis and Treatment of a Rare and Challenging Cancer
Otolaryngologists View Resident Work-Hour Restrictions: ACS calls for in-depth investigation before mandating further restrictions
In response to many national calls to enhance patient safety, the Accreditation Council for Graduate Medical Education (ACGME) mandated a maximum 80-hour workweek for all residents beginning in 2003.
Otolaryngologists-Head and Neck Surgeons Urged: Be Part of the Solution in Health Care Reform
With the crisis in the financial markets reaching what many call historic proportions, another crisis long brewing is threatening to surface that, if some experts are correct, could have even greater consequences than the financial crisis for the US health care system.
New Medicare Audiology Billing Takes Effect
As of October 1, all audiologists who provide services to Medicare patients must use their own National Provider Identifier (NPI) on claims submitted to the Centers for Medicare and Medicaid Services (CMS).
New Cerumen Guidelines Development Process Reflects AAO-HNS’s Methodical Approach
In September, the American Association of Otolaryngologists-Head and Neck Surgeons (AAO-HNS) published the first clinical practice guidelines on the removal of impacted cerumen (Otolaryngol Head Neck Surg 2008;139:S1-S21).
The Political Process: Get Involved-or Not
Politics is not a four-letter word.
Pregabalin Shows Promise as Treatment Option for Laryngeal Sensory Neuropathy
Treatment with the antiepileptic drug pregabalin (Lyrica) appears to relieve symptoms among patients with laryngeal sensory neuropathy, researchers reported at the 88th annual meeting of the American Broncho-Esophagological Association.
- « Previous Page
- 1
- …
- 297
- 298
- 299
- 300
- 301
- …
- 332
- Next Page »